Is Abbott Laboratories a Dividend Bargain After Its 2026 Selloff?
FROM THE WIRE · FINANCE.YAHOO.COM
Abbott Laboratories (NYSE:ABT) is a business that is not showcasing any rapid growth trends. However, what makes it an attractive investment prospect is the company's consistent track record of incremental dividends, with 411 consecutive quarterly payouts since 1924. Along with…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralAbbott has fallen 22% in 2026 but offers 411 consecutive quarterly dividend payments since 1924.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Abbott has paid 411 consecutive quarterly dividends since 1924.
- 02The stock is down 22.18% year-to-date and has lagged the S&P 500 by 42 percentage points.
- 03Abbott shows no rapid growth trends but has a solid underlying business mix.
- 04The stock closed at $97.50 on October 2 after a bearish run in 2026.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets